State Ledger
Company profile

Organon & Co. CIK 1821825

Ticker
OGN (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Jersey City, NJ 07302
Fiscal year end
2025 (FY)
Market Data
Close
$13.77
Change
-$0.01
Change %
-0.04%
Volume
177,310

OGN · trading date Oct 13, 2026 · previous close $13.78 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$6.22B
Net income
$187.00M
Total assets
$12.87B
Total liabilities
$12.12B
Stockholders' equity
$752.00M
Cash & equivalents
$574.00M
Operating income
—
Operating cash flow
$700.00M
Capital expenditures
$162.00M

Fiscal year 2025, via 10-K filed 2026-02-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
3.0%
Free cash flow
$538.00M
Free cash flow margin
8.7%
Liabilities / assets
94.2%
Equity / assets
5.8%
CapEx / revenue
2.6%
Operating cash flow / net income
3.74×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $6.22B $187.00M $12.87B $12.12B $752.00M
2024 $6.40B $864.00M $13.10B $12.63B $472.00M
2023 $6.26B $1.02B $12.06B $12.13B -$70.00M
2022 $6.17B $917.00M $10.96B $11.85B -$892.00M
2021 $6.30B $1.35B $10.68B — -$1.51B
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G
2026-08-14
Financials filed via
Form 10-K
filed 2026-02-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Jersey City, NJ 07302
30 HUDSON STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies